SE9201331D0 - Protein l och hybridproteiner daerav - Google Patents
Protein l och hybridproteiner daeravInfo
- Publication number
- SE9201331D0 SE9201331D0 SE9201331A SE9201331A SE9201331D0 SE 9201331 D0 SE9201331 D0 SE 9201331D0 SE 9201331 A SE9201331 A SE 9201331A SE 9201331 A SE9201331 A SE 9201331A SE 9201331 D0 SE9201331 D0 SE 9201331D0
- Authority
- SE
- Sweden
- Prior art keywords
- proteins
- protein
- sequences
- relates
- hybrid proteins
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/33—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Clostridium (G)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/034—Fusion polypeptide containing a localisation/targetting motif containing a motif for targeting to the periplasmic space of Gram negative bacteria as a soluble protein, i.e. signal sequence should be cleaved
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
- C07K2319/705—Fusion polypeptide containing domain for protein-protein interaction containing a protein-A fusion
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/975—Kit
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Priority Applications (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9201331A SE9201331D0 (sv) | 1992-04-28 | 1992-04-28 | Protein l och hybridproteiner daerav |
JP51918393A JP3462209B2 (ja) | 1992-04-28 | 1993-04-28 | プロテインlおよびそのハイブリッドプロテイン類 |
US08/325,278 US6822075B2 (en) | 1992-04-28 | 1993-04-28 | Protein L and hybrid proteins thereof |
PCT/SE1993/000375 WO1993022342A1 (en) | 1992-04-28 | 1993-04-28 | Protein l and hybrid proteins thereof |
DE69333042T DE69333042T2 (de) | 1992-04-28 | 1993-04-28 | Protein l und entsprechenden proteinhybriden |
EP93912053A EP0662086B1 (en) | 1992-04-28 | 1993-04-28 | Protein l and hybrid proteins thereof |
US08/795,475 US5965390A (en) | 1992-04-28 | 1997-02-11 | Protein L and hybrid proteins thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9201331A SE9201331D0 (sv) | 1992-04-28 | 1992-04-28 | Protein l och hybridproteiner daerav |
Publications (1)
Publication Number | Publication Date |
---|---|
SE9201331D0 true SE9201331D0 (sv) | 1992-04-28 |
Family
ID=20386082
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE9201331A SE9201331D0 (sv) | 1992-04-28 | 1992-04-28 | Protein l och hybridproteiner daerav |
Country Status (6)
Country | Link |
---|---|
US (2) | US6822075B2 (xx) |
EP (1) | EP0662086B1 (xx) |
JP (1) | JP3462209B2 (xx) |
DE (1) | DE69333042T2 (xx) |
SE (1) | SE9201331D0 (xx) |
WO (1) | WO1993022342A1 (xx) |
Families Citing this family (39)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6737521B1 (en) * | 1990-05-11 | 2004-05-18 | The Rockefeller University | Delivery and expression of a hybrid surface protein on the surface of gram positive bacteria |
SE9201331D0 (sv) * | 1992-04-28 | 1992-04-28 | Hightech Receptor C O Active | Protein l och hybridproteiner daerav |
US7037680B2 (en) * | 1993-09-21 | 2006-05-02 | The United States Of America As Represented By The Secretary Of The Army | Recombinant light chains of botulinum neurotoxins and light chain fusion proteins for use in research and clinical therapy |
AUPM885194A0 (en) * | 1994-10-14 | 1994-11-10 | Council Of The Queensland Institute Of Medical Research, The | Synthetic peptides and vaccines comprising same |
CA2249455A1 (en) * | 1996-03-26 | 1997-10-02 | Amrad Operations Pty. Ltd. | Precursors of catalytic antibodies |
AUPO930697A0 (en) * | 1997-09-19 | 1997-10-09 | Walter And Eliza Hall Institute Of Medical Research, The | Catalytic antibodies and a method of producing same |
US20040154053A1 (en) * | 1998-03-20 | 2004-08-05 | Wyatt Paul | Signal transduction protein involved in plant dehiscence |
EP1114161B1 (en) | 1998-09-14 | 2004-03-03 | Affitech As | Immunoglobulin binding protein |
US7345217B2 (en) | 1998-09-22 | 2008-03-18 | Mendel Biotechnology, Inc. | Polynucleotides and polypeptides in plants |
US8124348B2 (en) | 2000-08-23 | 2012-02-28 | Jonathan Zmuda | Oral fluid rapid assay for hepatitis C virus (HCV) antibodies using non-antibody labeling of IgA molecules recognizing HCV peptide epitopes |
US7939715B2 (en) | 2000-11-16 | 2011-05-10 | Mendel Biotechnology, Inc. | Plants with improved yield and stress tolerance |
NZ526822A (en) * | 2000-12-19 | 2005-03-24 | Sembiosys Genetics Inc | Methods for the production of multimeric proteins for producing an oil body associated with a recombinant protein complex preferably thioredoxin or an immunoglobin, in transgenic plants and their use in compositons for reducing allergenicity of food |
US7098383B2 (en) * | 2000-12-19 | 2006-08-29 | Sembiosys Genetics Inc. | Methods for the production of multimeric immunoglobulins, and related compositions |
US20030167524A1 (en) * | 2000-12-19 | 2003-09-04 | Rooijen Gijs Van | Methods for the production of multimeric protein complexes, and related compositions |
US20060179514A1 (en) * | 2001-07-05 | 2006-08-10 | Sembiosys Genetics, Inc. | Methods for the production of multimeric protein complexes, and related compositions |
US8426678B2 (en) | 2002-09-18 | 2013-04-23 | Mendel Biotechnology, Inc. | Polynucleotides and polypeptides in plants |
US7255867B2 (en) * | 2002-11-15 | 2007-08-14 | Id Biomedical Corporation Of Quebec | Vaccine |
WO2004076634A2 (en) * | 2003-02-24 | 2004-09-10 | Ira Sanders | Cell membrane translocation of regulated snare inhibitors , compositions therefor, and methods for treatment of disease |
JP2005112827A (ja) * | 2003-10-10 | 2005-04-28 | National Institute Of Advanced Industrial & Technology | 抗体アフィニティ担体 |
WO2005113584A1 (en) * | 2004-04-29 | 2005-12-01 | Board Of Regents, University Of Texas System | Methods and compositions comprising protein l immunoglobulin binding domains for cell-specific targeting |
US8221998B2 (en) * | 2005-05-20 | 2012-07-17 | Glaxosmithkline Llc | Expression of protein GB1 domain fusion proteins in mammalian cells |
US7741128B2 (en) * | 2005-05-23 | 2010-06-22 | University Of Hawaii | Cooperative reporter systems, components, and methods for analyte detection |
US10822396B2 (en) * | 2009-12-15 | 2020-11-03 | MuHyeon CHOE | Repeat-chain for the production of dimer, multimer, multimer complex and super-complex |
AU2012328322A1 (en) | 2011-10-27 | 2014-06-12 | Genmab A/S | Production of heterodimeric proteins |
WO2014193193A1 (ko) * | 2013-05-30 | 2014-12-04 | Choe Muhyeon | 반복사슬과 단량체의 복합체 간의 교차결속에 의해 형성된 초복합체 및 이의 용도 |
US9569513B1 (en) * | 2013-09-10 | 2017-02-14 | Amazon Technologies, Inc. | Conditional master election in distributed databases |
JP6731345B2 (ja) | 2014-08-28 | 2020-07-29 | 株式会社カネカ | 免疫グロブリンg結合性ペプチド |
JP6369807B2 (ja) * | 2014-10-21 | 2018-08-08 | 株式会社プロテイン・エクスプレス | プロテインl変異体 |
DK3233892T3 (da) | 2014-12-17 | 2024-04-08 | Cytiva Bioprocess R & D Ab | Modificerede kappa-letkæde-bindende polypeptider |
EP3252158A4 (en) | 2015-01-26 | 2018-07-18 | Kaneka Corporation | Mutant immunoglobulin kappa chain variable region-binding peptide |
JPWO2016121701A1 (ja) * | 2015-01-26 | 2017-11-09 | 株式会社カネカ | 免疫グロブリンκ鎖可変領域含有タンパク質精製用アフィニティー分離マトリックス |
WO2017191747A1 (ja) * | 2016-05-06 | 2017-11-09 | 株式会社カネカ | κ鎖可変領域を含むタンパク質の製造方法 |
WO2017195638A1 (ja) | 2016-05-09 | 2017-11-16 | 株式会社カネカ | 抗体またはκ鎖可変領域含有抗体断片の精製方法 |
JP6983419B2 (ja) * | 2017-02-08 | 2021-12-17 | 国立大学法人東京工業大学 | 抗原検出又は測定用キット |
WO2021252498A1 (en) | 2020-06-12 | 2021-12-16 | New England Biolabs, Inc. | Compositions and methods for detecting molecular targets on chromosomal dna |
WO2022216157A1 (en) * | 2021-04-09 | 2022-10-13 | Stichting Radboud Universiteit | Off the shelf proximity biotinylation enzyme |
GB202112386D0 (en) | 2021-08-31 | 2021-10-13 | Cytiva Bioprocess R & D Ab | Modified kappa light chain-binding polypeptides |
GB202203640D0 (en) | 2022-03-16 | 2022-04-27 | Cytiva Bioprocess R & D Ab | Alkali-stabilized kappa light chain-binding separation matrix |
WO2023247468A2 (en) | 2022-06-22 | 2023-12-28 | Puridify Limited | Kappa light chain-binding convection matrix |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE459503B (sv) * | 1985-05-03 | 1989-07-10 | Excorim Kommanditbolag | Hybrid-dna-molekyl innefattande dna-sekvens som kodar foer protein g samt foerfarande foer framstaellning av protein g |
US5312901A (en) | 1986-02-14 | 1994-05-17 | Pharmacia Lkb Biotechnology Ab | Cloned streptococcal genes encoding protein G and their use to construct recombinant microorganisms to produce protein G |
SE459662B (sv) | 1986-03-21 | 1989-07-24 | Pharmacia Ab | Hybrid-dna-molekyl som kodar foer ett protein med samma igg specificitet som protein g, plasmid innehaallande densamma samt foerfarande foer framstaellning av proteinet |
US4876194A (en) * | 1986-07-22 | 1989-10-24 | Hightech Receptor Ab | Protein L and subfragments thereof, with immunoglobulin binding activity, a process for preparing thereof, reagent kit, pharmaceutical composition and a peptococcus magnus strain |
JP2871709B2 (ja) * | 1988-11-21 | 1999-03-17 | 住友製薬株式会社 | 免疫グロブリンg結合活性を有する新規な蛋白質プロテインh、該蛋白質をコードする遺伝子及び該蛋白質の製造法 |
SE466259B (sv) * | 1990-05-31 | 1992-01-20 | Arne Forsgren | Protein d - ett igd-bindande protein fraan haemophilus influenzae, samt anvaendning av detta foer analys, vacciner och uppreningsaendamaal |
SE9002212D0 (sv) * | 1990-06-21 | 1990-06-21 | Hightech Receptor Ab | Igg binding protein |
US5736362A (en) * | 1990-10-26 | 1998-04-07 | The University Of Melbourne | Ryegrass pollen allergen |
SE9201331D0 (sv) * | 1992-04-28 | 1992-04-28 | Hightech Receptor C O Active | Protein l och hybridproteiner daerav |
WO1993022439A1 (en) * | 1992-05-07 | 1993-11-11 | Microbiological Research Authority | Immunoglobulin binding proteins derived from l protein and their uses |
US5977336A (en) * | 1993-03-16 | 1999-11-02 | St. Louis University | High molecular weight surface proteins of non-typeable haemophilus |
EP1114161B1 (en) * | 1998-09-14 | 2004-03-03 | Affitech As | Immunoglobulin binding protein |
GB9929937D0 (en) * | 1999-12-17 | 2000-02-09 | Actinova Ltd | Antigen delivery |
-
1992
- 1992-04-28 SE SE9201331A patent/SE9201331D0/xx unknown
-
1993
- 1993-04-28 EP EP93912053A patent/EP0662086B1/en not_active Expired - Lifetime
- 1993-04-28 US US08/325,278 patent/US6822075B2/en not_active Expired - Lifetime
- 1993-04-28 JP JP51918393A patent/JP3462209B2/ja not_active Expired - Lifetime
- 1993-04-28 DE DE69333042T patent/DE69333042T2/de not_active Expired - Lifetime
- 1993-04-28 WO PCT/SE1993/000375 patent/WO1993022342A1/en active IP Right Grant
-
1997
- 1997-02-11 US US08/795,475 patent/US5965390A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
JPH07506573A (ja) | 1995-07-20 |
US6822075B2 (en) | 2004-11-23 |
EP0662086B1 (en) | 2003-06-11 |
US20030027283A1 (en) | 2003-02-06 |
JP3462209B2 (ja) | 2003-11-05 |
DE69333042T2 (de) | 2004-05-06 |
EP0662086A1 (en) | 1995-07-12 |
WO1993022342A1 (en) | 1993-11-11 |
DE69333042D1 (de) | 2003-07-17 |
US5965390A (en) | 1999-10-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE9201331D0 (sv) | Protein l och hybridproteiner daerav | |
CA2290485A1 (en) | Method for the production of non-immunogenic proteins | |
ATE130765T1 (de) | Gentechnologisch veränderte immunglobuline. | |
ATE213507T1 (de) | Methode zur bindung von material an das beta- amyloid-peptid | |
ATE353362T1 (de) | Neuartige ctla4/cd28 liganden und deren anwendungen | |
DK19290D0 (da) | Molekulaer samling af antistofgener, antistoffer fremstillet derved samt anvendelse deraf | |
DE69131580D1 (de) | GDF-1 und UOG1 Proteine | |
DE69637148D1 (de) | Nukleinsäuremoleküle, proteine und peptide, die im zusammenhang stehen mit dickdarmzellen und dickdarm-krebszellen | |
EP1862472A3 (en) | Chlamydia protein, gene sequence and uses thereof | |
DE69932813D1 (de) | Nukleinsäurebindungsproteine | |
CY1113218T1 (el) | Υβριδιο και διμερης εκφραση πρωτεϊνων ναϊσσεριας | |
WO2003092630A3 (en) | Identification of novel broadly cross-reactive neutralizing human monoclonal antibodies using sequential antigen panning of phage display libraries | |
DK0640135T3 (da) | Immunoglobulinbindende proteiner, der er afledt af protein L, og anvendelser af disse | |
ATE368688T1 (de) | Peptide, deren herstellung und verwendung zur bindung von immunglobulinen | |
WO1997008314A3 (en) | Telomere repeat binding factor and diagnostic and therapeutic use thereof | |
ATE177758T1 (de) | Synthetische peptide, antikörper dagegen und ihre verwendung | |
DE69433690D1 (de) | Chimere proteine, welche borrelia polypeptide beinhalten, verwendungen dafür | |
GB9307371D0 (en) | Fusion proteins | |
ATE258598T1 (de) | Verfahren zur proteinrückfaltung durch verwendung zwitterionischer wirkstoffe von niedrigem molekulargewicht | |
DE69333382D1 (de) | Hyaluronan rezeptor (rezeptor durch hyaluronan verurzachte bewelichkeit) und hyaluronan bindende peptide | |
WO1998021333A3 (en) | Nucleic acid encoding schwannomin-binding-proteins and products related thereto | |
EP1576157A4 (en) | FLUORESCENCE PROTEINS FROM COPEPODA SPECIES AND METHOD FOR USE THEREOF | |
FR2692282B1 (fr) | Clonage du gene codant pour la proteine gp28.5 de t. gondii; fragments peptidiques issus de ladite proteine et leurs applications. | |
AU4375493A (en) | Isolated protein receptors, antibodies which bind thereto, nucleic acid sequence coding therefor, and uses thereof | |
NZ500151A (en) | A general method for attaching DNA molecule comprising non-antibody target molecule (eg. CTLA-4 or L-selectin), antigen or epitope sequence, and optionally a polypeptide sequence |